We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Physiological and Pathophysiological Roles of IgM Fc Receptor (FcµR) Isoforms.
- Authors
Kubagawa, Hiromi; Clark, Caren; Skopnik, Christopher M.; Mahmoudi Aliabadi, Pedram; Al-Qaisi, Khlowd; Teuber, Ruth; Jani, Peter K.; Radbruch, Andreas; Melchers, Fritz; Engels, Niklas; Wienands, Jürgen
- Abstract
IgM is the first antibody to emerge during phylogeny, ontogeny, and immune responses and serves as a first line of defense. Effector proteins interacting with the Fc portion of IgM, such as complement and its receptors, have been extensively studied for their functions. IgM Fc receptor (FcµR), identified in 2009, is the newest member of the FcR family and is intriguingly expressed by lymphocytes only, suggesting the existence of distinct functions as compared to the FcRs for switched Ig isotypes, which are expressed by various immune and non-hematopoietic cells as central mediators of antibody-triggered responses by coupling the adaptive and innate immune responses. Results from FcµR-deficient mice suggest a regulatory function of FcµR in B cell tolerance, as evidenced by their propensity to produce autoantibodies of both IgM and IgG isotypes. In this article, we discuss conflicting views about the cellular distribution and potential functions of FcµR. The signaling function of the Ig-tail tyrosine-like motif in the FcµR cytoplasmic domain is now formally shown by substitutional experiments with the IgG2 B cell receptor. The potential adaptor protein associating with FcµR and the potential cleavage of its C-terminal cytoplasmic tail after IgM binding are still enigmatic. Critical amino acid residues in the Ig-like domain of FcµR for interacting with the IgM Cµ4 domain and the mode of interaction are now defined by crystallographic and cryo-electron microscopic analyses. Some discrepancies on these interactions are discussed. Finally, elevated levels of a soluble FcµR isoform in serum samples are described as the consequence of persistent B cell receptor stimulation, as seen in chronic lymphocytic leukemia and probably in antibody-mediated autoimmune disorders.
- Subjects
B cell receptors; CHRONIC lymphocytic leukemia; AMINO acid residues; B cells; IMMUNE response; COMPLEMENT receptors
- Publication
International Journal of Molecular Sciences, 2023, Vol 24, Issue 6, p5728
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms24065728